Carl Quintanilla, Jim Cramer and David Faber focused on stocks' positive start to a new week of trading, Wall Street hoping that President Trump is recovering from COVID-19 and that the stimulus talks will result in Congress passing a relief bill.
They also discussed the CEO of Regeneron telling CNBC that he hopes the company's antibody cocktail will help President Trump recover from COVID-19. The virus continuing to impact the movie theater industry as Regal Cinemas decides to suspend operations at its U.S. theaters. M&A in the spotlight as Bristol-Myers agrees to acquire drug maker MyoKardia in a $13-billion deal.